U.S. Pharmaceutical Corporation
7 drugs in NADAC|0 Generic,7 Brand
U.S. Pharmaceutical Corporation lists 7 NDCs in the CMS NADAC file (0 generic, 7 brand), at an average NADAC of $0.78 per unit, with a week-over-week move of +10.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
7
0G / 7B
Avg Price / Unit
$0.7815
$0.57 – $1.16
Avg 7d Change
+10.01%
Across 5 drugs with changes
7d Activity
of 7 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Weekly brief
Featured in the latest weekly brief
This manufacturer is surfaced in the latest executive summary of notable weekly NADAC movement.
Lead market
Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Nicotinic Acid therapeutic class
Review the broader class where U.S. Pharmaceutical Corporation has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does U.S. Pharmaceutical Corporation make?
U.S. Pharmaceutical Corporation lists 7 NDCs in the CMS NADAC file — 0 generic and 7 brand products.
What is the average price of U.S. Pharmaceutical Corporation drugs?
The average NADAC across U.S. Pharmaceutical Corporation's portfolio is $0.7815 per unit, ranging from $0.5699 to $1.1610.
What types of drugs does U.S. Pharmaceutical Corporation make?
U.S. Pharmaceutical Corporation makes drugs across 11 FDA pharmacologic classes. The most common by NDC count are Nicotinic Acid (6), Vitamin C (6), Vitamin B6 Analog (4), Calculi Dissolution Agent (2), Copper Absorption Inhibitor (2).
Has U.S. Pharmaceutical Corporation had any drug recalls?
No FDA enforcement recalls are matched to U.S. Pharmaceutical Corporation in the openFDA feed.
How has U.S. Pharmaceutical Corporation's pricing changed recently?
Over the past 7 days, 5 U.S. Pharmaceutical Corporation products rose and 0 fell, with a portfolio-wide average change of +10.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CONCEPT DHA CAPSULE Vitamin- Mineral Omega-3 Supplement | $1.1610 per EA | +10.01% |
CONCEPT OB CAPSULE Vitamin Mineral Supplement | $0.8902 per EA | — |
INTEGRA PLUS CAPSULE Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement | $0.7650 per EA | +10.01% |
NOREL AD TABLET acetaminophen, chlorpheniramine maleate, and phenylephrine HCl | $0.7451 per EA | — |
INTEGRA PLUS CAPSULE Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement | $0.7210 per EA | +10.01% |
INTEGRA F CAPSULE Ferrous Fumarate and Polysacchride Iron Complex and Folic Acid | $0.6185 per EA | +10.03% |
INTEGRA F CAPSULE Ferrous Fumarate and Polysacchride Iron Complex and Folic Acid | $0.5699 per EA | +10.01% |